{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:47:32Z","timestamp":1785858452770,"version":"3.56.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,15]]},"DOI":"10.1097\/01.tp.0000162980.68628.5a","type":"journal-article","created":{"date-parts":[[2005,7,6]],"date-time":"2005-07-06T09:18:34Z","timestamp":1120641514000},"page":"41-46","source":"Crossref","is-referenced-by-count":58,"title":["A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients"],"prefix":"10.1097","volume":"80","author":[{"given":"Karen L.","family":"Hardinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Bohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/00007890-199606150-00005","article-title":"One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.","volume":"61","author":"Vincenti","year":"1996","journal-title":"Transplantation"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-199708150-00012","article-title":"Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.","volume":"64","author":"Mayer","year":"1997","journal-title":"Transplantation"},{"key":"R4-9-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/01.TP.0000069831.76067.22","article-title":"Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine +mycophenolate mofetil after cadaveric kidney transplantation: results at three years.","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/01.TP.0000090865.20886.B7","article-title":"Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.","volume":"76","author":"Irish","year":"2003","journal-title":"Transplantation"},{"key":"R7-9-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.TP.0000132329.67611.3F","article-title":"Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.","volume":"78","author":"Hardinger","year":"2004","journal-title":"Transplantation"},{"key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R11-9-20210129","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R13-9-20210129","article-title":"2003 Drug Topics Red Book.","year":"2003"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/01.TP.0000081042.67285.91","article-title":"A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.","volume":"76","author":"Goggins","year":"2003","journal-title":"Transplantation"},{"key":"R15-9-20210129","first-page":"672","article-title":"Transplantation.","author":"Rodino","year":"1999"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.","volume":"23","author":"van Gelder","year":"2001","journal-title":"Ther Drug Monit"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000162980.68628.5A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:53:44Z","timestamp":1785855224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200507150-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,15]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000162980.68628.5a","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7,15]]}}}